Item 8.01 Other Events.
On
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits. Exhibit No. Description 99.1 Press release datedJanuary 19, 2022 -2-
© Edgar Online, source
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.99 USD | -2.93% | -2.45% | -71.24% |
07-08 | Immix Biopharma Doses First Patient in US AL Amyloidosis Trial With NXC-201 | MT |
07-08 | Immix Biopharma, Inc. Doses 1st Patient in U.S. AL Amyloidosis Trial with CAR-T NXC-201 | CI |
Item 8.01 Other Events.
On
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits. Exhibit No. Description 99.1 Press release datedJanuary 19, 2022 -2-
© Edgar Online, source
1st Jan change | Capi. | |
---|---|---|
-71.24% | 54.15M | |
+7.46% | 100B | |
+8.42% | 42.34B | |
-12.13% | 32.76B | |
+79.40% | 29.46B | |
-12.09% | 16.31B | |
+2.45% | 14.39B | |
-1.90% | 12.23B | |
+177.16% | 10.47B | |
+1.65% | 8.97B |